MPS I-DISEASE
Drug
GENZYME CORPORATION
Total Payments
$181,090
Transactions
242
Doctors
94
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $48,985 | 89 | 37 |
| 2018 | $55,162 | 58 | 10 |
| 2017 | $76,943 | 95 | 47 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $179,174 | 142 | 98.9% |
| Food and Beverage | $1,915 | 100 | 1.1% |
Payments by Type
Research
$179,174
142 transactions
General
$1,915
100 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MPS1 Registry | GENZYME CORPORATION | $38,611 | 0 |
| Q4 2016 MPSI LSD Registry | GENZYME CORPORATION | $28,118 | 0 |
| MPS IDISEASE (612690303) | GENZYME CORPORATION | $27,666 | 0 |
| MPS1 Disease Registry Protocol and Pregnancy Subregistry Protocol | GENZYME CORPORATION | $13,261 | 0 |
| Q2 2017 MPSI LSD Registry | GENZYME CORPORATION | $12,751 | 0 |
| Q1 2017 MPSI LSD Registry | GENZYME CORPORATION | $11,870 | 0 |
| MPS-I LSD Data Registry | GENZYME CORPORATION | $11,053 | 0 |
| Q3 2017 MPSI LSD Registry | GENZYME CORPORATION | $10,106 | 0 |
| MPS I Disease Registry | GENZYME CORPORATION | $9,501 | 0 |
| MPSI Disease Registry Protocol and Pregnancy Sub-Registry | SANOFI US SERVICES INC. | $5,440 | 0 |
| MPSI Registry Program | GENZYME CORPORATION | $4,080 | 0 |
| MPS1 Disease Registry IRB fee for initial review & site start up fees | GENZYME CORPORATION | $2,640 | 0 |
| IRB Annual Review | GENZYME CORPORATION | $2,040 | 0 |
| Rare Disease Registry Program | GENZYME CORPORATION | $875.00 | 0 |
| IRB Annual Review for Gaucher, Pompe, Fabry and MPSI Registry | GENZYME CORPORATION | $680.00 | 0 |
| MPS1 Disease Registry Protocol and Pregnancy Sub-Registry Protocol | GENZYME CORPORATION | $245.00 | 0 |
| MPS1 Disease Registry IRB fee for annual review | GENZYME CORPORATION | $237.50 | 0 |
Top Doctors Receiving Payments for MPS I-DISEASE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Research Triangle Park, NC | $179,174 | 142 |
| Mary Gallagher | Specialist | New York, NY | $90.20 | 1 |
| , MD | Pediatric Hematology-Oncology | Minneapolis, MN | $66.00 | 1 |
| , M.D | Ophthalmology | Suffern, NY | $57.63 | 3 |
| , MD | Pediatric Endocrinology | Sleepy Hollow, NY | $44.72 | 2 |
| , MD | Pediatric Endocrinology | Birmingham, AL | $38.19 | 1 |
| , M.D., M.P.H | Pediatric Endocrinology | Phoenix, AZ | $34.38 | 2 |
| , M.D | Family Medicine | Hiawatha, KS | $32.39 | 2 |
| , M.D | Pediatrics | Fremont, NE | $26.47 | 2 |
| , MD | Pediatric Cardiology | Knoxville, TN | $24.39 | 1 |
| , M.D | Pediatric Cardiology | Knoxville, TN | $24.39 | 1 |
| , M.D | Clinical Genetics (M.D.) | New Orleans, LA | $22.97 | 1 |
| , MD | Endocrinology, Diabetes & Metabolism | Phoenix, AZ | $22.92 | 1 |
| , MD | Pediatric Surgery | Chapel Hill, NC | $22.89 | 1 |
| , MD | Surgery | Concord, NC | $22.89 | 1 |
| Marion Kessler | — | Sleepy Hollow, NY | $22.83 | 1 |
| Dan Handelsman | — | Hawthorne, NY | $22.83 | 1 |
| , M.D | Pediatric Endocrinology | Sleepy Hollow, NY | $22.83 | 1 |
| Payal Patel | Pediatric Endocrinology | Sleepy Hollow, NY | $22.83 | 1 |
| , MD | Pediatric Otolaryngology | Ardsley, NY | $22.76 | 1 |
| , M.D | Sleep Medicine | Ardsley, NY | $22.76 | 1 |
| , MD | Pediatric Endocrinology | Sleepy Hollow, NY | $21.89 | 1 |
| , M.D | Pediatrics | Cheektowaga, NY | $21.83 | 1 |
| , MD | Specialist | Las Vegas, NV | $21.63 | 1 |
| , MD | Ophthalmology | Suffern, NY | $21.32 | 1 |
Ad
Manufacturing Companies
- GENZYME CORPORATION $175,650
- SANOFI US SERVICES INC. $5,440
Product Information
- Type Drug
- Total Payments $181,090
- Total Doctors 94
- Transactions 242
About MPS I-DISEASE
MPS I-DISEASE is a drug associated with $181,090 in payments to 94 healthcare providers, recorded across 242 transactions in the CMS Open Payments database. The primary manufacturer is GENZYME CORPORATION.
Payment data is available from 2017 to 2019. In 2019, $48,985 was paid across 89 transactions to 37 doctors.
The most common payment nature for MPS I-DISEASE is "Unspecified" ($179,174, 98.9% of total).
MPS I-DISEASE is associated with 17 research studies, including "MPS1 Registry" ($38,611).